View in EDS

Enfortumab Vedotin plus Pembrolizumab as Perioperative Therapy.

Saved in:
Bibliographic Details
Title: Enfortumab Vedotin plus Pembrolizumab as Perioperative Therapy.
Authors: Singh P; Department of Medicine, Mayo Clinic Alix School of Medicine, Phoenix, AZ., Lerner SP; Department of Urology, Baylor College of Medicine, Houston.
Source: The New England journal of medicine [N Engl J Med] 2026 Apr 02; Vol. 394 (13), pp. 1334-1336. Date of Electronic Publication: 2026 Feb 18.
Publication Type: Editorial
Journal Info: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41707168
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Enfortumab Vedotin plus Pembrolizumab as Perioperative Therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Singh+P%22">Singh P</searchLink>; Department of Medicine, Mayo Clinic Alix School of Medicine, Phoenix, AZ.<br /><searchLink fieldCode="AU" term="%22Lerner+SP%22">Lerner SP</searchLink>; Department of Urology, Baylor College of Medicine, Houston.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220255562%22">The New England journal of medicine</searchLink> [N Engl J Med] 2026 Apr 02; Vol. 394 (13), pp. 1334-1336. <i>Date of Electronic Publication: </i>2026 Feb 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Editorial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Massachusetts+Medical+Society%22">Massachusetts Medical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0255562 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1533-4406 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200284793%22">00284793 </searchLink><i>NLM ISO Abbreviation: </i>N Engl J Med <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41707168
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1056/NEJMe2515777
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1334
    Titles:
      – TitleFull: Enfortumab Vedotin plus Pembrolizumab as Perioperative Therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Singh P
      – PersonEntity:
          Name:
            NameFull: Lerner SP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 04
              Text: 2026 Apr 02
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1533-4406
          Numbering:
            – Type: volume
              Value: 394
            – Type: issue
              Value: 13
          Titles:
            – TitleFull: The New England journal of medicine
              Type: main
ResultId 1